|
1 Introduction to Scientific Integrity and Research Ethics |
|
|
1 | (12) |
|
1.1 What Is "Science" and Its Ethos? |
|
|
1 | (1) |
|
1.2 Early Lapses in Science and Ethics |
|
|
2 | (1) |
|
1.3 Nuremberg and Its Progeny |
|
|
3 | (2) |
|
1.4 The Origins of the Nuremberg Principles |
|
|
5 | (3) |
|
|
5 | (1) |
|
|
6 | (1) |
|
1.4.3 Consequentialism/Utilitarianism |
|
|
7 | (1) |
|
1.5 Some Problems with Ethical Theories |
|
|
8 | (1) |
|
1.6 The Modern Bioethics Regime |
|
|
9 | (4) |
|
|
12 | (1) |
|
|
13 | (12) |
|
2.1 Sources and Citations |
|
|
13 | (3) |
|
2.2 Data Collection, Manipulation, and Curation |
|
|
16 | (2) |
|
2.3 Correlation Without Causation |
|
|
18 | (2) |
|
2.4 Publication Bias as Part of the Problem |
|
|
20 | (1) |
|
|
21 | (1) |
|
|
22 | (3) |
|
|
22 | (3) |
|
|
25 | (12) |
|
|
25 | (1) |
|
|
26 | (1) |
|
3.3 Duties of Authors to Each Other |
|
|
27 | (1) |
|
|
28 | (2) |
|
3.5 The Korean Stem Cell Fraud |
|
|
30 | (2) |
|
3.6 What Counts as Your Work? |
|
|
32 | (2) |
|
3.7 Salami Science and Self-Plagiarism |
|
|
34 | (1) |
|
|
34 | (3) |
|
|
35 | (2) |
|
4 Issues in Intellectual Property and Science |
|
|
37 | (12) |
|
4.1 What Is Intellectual Property (IP)? |
|
|
37 | (1) |
|
4.2 A Short and Sweet History of IP |
|
|
38 | (3) |
|
|
41 | (1) |
|
4.4 Not Treading on IP During Research |
|
|
42 | (1) |
|
4.5 Science and Competition |
|
|
43 | (1) |
|
4.6 Nature vs. Artifacts: What Ought to Be Monopolized Consistent with the Ethos of Science? |
|
|
44 | (1) |
|
4.7 Open Science as an Alternative |
|
|
45 | (1) |
|
|
46 | (3) |
|
|
47 | (2) |
|
|
49 | (12) |
|
5.1 What Is a Conflict of Interest? |
|
|
49 | (1) |
|
5.2 The Interests of Science |
|
|
50 | (2) |
|
5.3 Interests of Scientists |
|
|
52 | (1) |
|
5.4 Other Institutional Interests |
|
|
53 | (1) |
|
5.5 Equipoise: A Duty of Scientists and Their Institutions |
|
|
54 | (1) |
|
5.6 The Problem of Private Ethics Committees and Contract Research Organizations |
|
|
55 | (1) |
|
|
56 | (2) |
|
|
58 | (3) |
|
|
59 | (2) |
|
6 Autonomy, Dignity, Beneficence, and Justice |
|
|
61 | (12) |
|
6.1 The Emergence of Medical Ethics |
|
|
61 | (2) |
|
|
63 | (2) |
|
|
65 | (1) |
|
6.4 Beneficence/Non-maleficence |
|
|
66 | (1) |
|
|
67 | (2) |
|
6.6 The Four Principles and "Care" Ethics |
|
|
69 | (4) |
|
|
71 | (2) |
|
7 Ethics Committees: Procedures and Duties |
|
|
73 | (12) |
|
7.1 Legal and Regulatory Framework |
|
|
73 | (1) |
|
7.2 Some Best Practices: Ethics Committees in Biomedicine |
|
|
74 | (2) |
|
7.3 Minimizing Risks: Stakeholders and Duties |
|
|
76 | (2) |
|
7.4 Clinical Trials: Methods and Duties |
|
|
78 | (2) |
|
7.5 Randomizing and Blinding |
|
|
80 | (1) |
|
7.6 Some Ethical Issues in Clinical Trials: Risk vs. Benefit |
|
|
81 | (1) |
|
|
82 | (1) |
|
7.8 Vulnerability and Justice |
|
|
83 | (2) |
|
|
83 | (2) |
|
8 Duties of Science to Society (and Vice Versa) |
|
|
85 | (12) |
|
|
85 | (1) |
|
|
86 | (2) |
|
|
88 | (1) |
|
|
89 | (2) |
|
|
91 | (1) |
|
8.6 Some Conclusions and Some Remaining Questions |
|
|
92 | (5) |
|
|
94 | (3) |
|
Appendix: Codes and Principles |
|
|
97 | (2) |
|
|
97 | (2) |
|
|
99 | (4) |
|
Recommendations Guiding Doctors in Clinical Research |
|
|
99 | (4) |
|
|
99 | (4) |
|
|
103 | (2) |
|
|
105 | |
|
Ethical Principles & Guidelines for Research Involving Human Subjects |
|
|
105 | (1) |
|
Part A Boundaries Between Practice & Research |
|
|
106 | (1) |
|
A Boundaries Between Practice and Research |
|
|
106 | (1) |
|
Part B Basic Ethical Principles |
|
|
107 | (3) |
|
B Basic Ethical Principles |
|
|
107 | (3) |
|
|
110 | |
|
|
110 | |